Frankfurt / Berlin – June 23, 2010 – Nanostart subsidiary MagForce Nanotechnologies AG, a medical technology company listed in the Entry Standard segment of the Frankfurt Stock Exchange, yesterday announced that it completed a placement of equity with German and international institutional investors.
A total of 80,190 newly issued shares were placed, with profit participation rights dating from January 1, 2009, at a price of EUR 42.00 per share. The gross proceeds from this capital increase of EUR 3,367,980.00 will go to the company and are to be used to finance its further growth.
This transaction increases the nominal capital of the company, until now EUR 3,773,198.00 divided into 3,773,198 shares at an imputed nominal value of EUR 1.00, by an amount of EUR 80,190.00, thus bringing its nominal capital to EUR 3,853,388.00. Subscription rights to existing shareholders were excluded by the authority under sec. 6 para. 3 of the company’s articles of incorporation (Satzung).About Nanostart:
Nanostart AG is the world’s leading nanotechnology investment company. The Frankfurt-based company provides venture capital financing for nanotechnology companies in various growth phases. It also provides the benefits of its experience and expertise to developers of financial instruments and to investors in the nanotechnology sector. For further information about the company, please visit www.nanostart.de.
About MagForce Nanotechnologies:
MagForce Nanotechnologies AG is a world-leading company in the area of nanotechnology-based cancer treatment. Its patented Nano-Cancer® therapy enables the targeted destruction of tumors using superparamagnetic nanoparticles to generate heat. The nanotechnology from MagForce represents a revolutionary approach to the future successful treatment of solid tumors.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the
Media contact:
Nanostart AG
Public Relations
Dr.
Goethestrasse 26-28
D-60313 Frankfurt
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 122
e-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
